Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma [Phase 1]
Phase 1 study of AMG 701 as monotherapy or with pomalidomide, with or without dexamethasone, in relapsed/refractory multiple myeloma has bee…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Study to Investigate Alternative Dosing Regimens of Belantamab Mafodotin in Participants With Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial evaluating alternative dosing regimens of belantamab mafodotin in relapsed or refractory multiple myeloma; the study is active…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients [Phase 1, Phase 2]
This clinical trial update reports HuL001 being studied in relapsed/refractory multiple myeloma in Phase 1/2, with enrollment currently by i…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Tasquinimod for the Treatment of Relapsed or Refractory Myeloma [Phase 1]
A University of Pennsylvania-sponsored Phase 1 trial of tasquinimod for relapsed or refractory multiple myeloma has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: A Study of the Bortezomib, Lenalidomide, and Dexamethasone Regimen for the Treatment of Newly Diagnosed Multiple Myeloma Patients
Clinical trial update on the bortezomib, lenalidomide, and dexamethasone regimen for newly diagnosed multiple myeloma, with the study status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma [NA]
A clinical trial evaluating high-dose chemotherapy with granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab [Phase 2]
Phase II study of a daratumumab-based combination (daratumumab, clarithromycin, pomalidomide, dexamethasone) in multiple myeloma patients pr…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: A Study of JNJ-64407564 in Japanese Participants With Relapsed or Refractory Multiple Myeloma [Phase 1]
A Phase 1 study of JNJ-64407564 in Japanese participants with relapsed or refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma [Phase 2]
A Phase 2 clinical trial evaluating pomalidomide, ixazomib, and dexamethasone with or without cyclophosphamide intensification in relapsed o…
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: Financial Difficulty in Patients With Blood Cancer
This clinical trial update notes the completion of a study evaluating financial difficulties experienced by patients with blood cancers, spe…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]
Phase 1 clinical trial evaluating CRISPR-edited allogeneic anti-BCMA CAR-T cell therapy in patients with relapsed or refractory multiple mye…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Study of 4 Bone Turnover Markers in Patients With Multiple Myeloma Treated With Intravenous Bisphosphonate in Routine Care
This clinical trial update reports on four bone turnover markers in multiple myeloma patients treated with intravenous bisphosphonates in ro…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: PROFAST Intervention in Precursor Multiple Myeloma [NA]
A Dana-Farber Cancer Institute trial evaluating the PROFAST intervention in precursor states to multiple myeloma has completed (NCT05565638)…
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Cardiovascular Reserve Evaluation in Survivors of Transplant, CREST Study
The CREST study update shows the cardiovascular reserve evaluation trial in transplant survivors is currently active but not recruiting, spo…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma [Phase 1]
This clinical trial update reports a Phase 1 study of UF-KURE-BCMA CAR-T Cells in relapsed or refractory multiple myeloma, with the study cu…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma Patients [Phase 4]
Phase 4 clinical trial completed evaluating mobilization of autologous hematopoietic stem cells using AMD3100 (plerixafor) in combination wi…
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy [Phase 2]
A Phase 2 clinical trial update notes evaluation of siltuximab for treating cytokine release syndrome (CRS) and ICANS related to CAR-T cell …
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Treatment of Primary Plasma Cell Leukaemia in Subjects Under the Age of 70 [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating treatment for primary plasma cell leukemia in patients under 70.
-
CLINICAL_TRIALS trial_result · 2025-09-18Clinical Trial Update: Evaluation of a Pain Management Intervention Preparatory to a Future Pragmatic Trial, ASCENT Study [NA]
This clinical trial update reports the completion of the ASCENT pain management intervention study with results posted for a future pragmati…
-
CLINICAL_TRIALS trial_result · 2025-09-17Clinical Trial Update: Tandem Auto Stem Cell Transplant With Melphalan Followed by Melphalan and Bortezomib in Patients With Multiple Myeloma [Phase 3]
Phase 3 trial evaluating tandem autologous stem cell transplant with melphalan followed by melphalan and bortezomib in adults with multiple …
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Augmented Virtual Reality for Reducing Pain, Stress, Anxiety and Improve Self Efficacy in Adult Cancer Patients Undergoing Chemotherapy in The West Bank [NA]
This completed clinical trial evaluated augmented virtual reality as a nonpharmacologic approach to reduce pain, stress, and anxiety and to …
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) [Phase 1]
Sanofi-sponsored multi-center open-label Phase 1b study in relapsed/refractory multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-12Clinical Trial Update: First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma [Phase 1]
Sanofi completed a first-in-human Phase 1 trial of SAR442085 as a single-agent therapy for relapsed or refractory multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial comparing autologous stem cell transplantation with pomalidomide maintenance versus continuous clarithromycin/pomalidomide/dex…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma [Phase 1, Phase 2]
terminated Phase 1/2 trial evaluating ide-cabtagene vicleucel (bb2121) combinations in multiple myeloma, reporting on safety and efficacy.